Actionable news
0
All posts from Actionable news
Actionable news in LLY: ELI LILLY & CO.,

Fitch Says Drug Approvals Are Driving Targeted Acquisitions In U.S. Pharma

Pfizer, Inc. NYSE:PFE, Bristol-Myers Squibb Company NYSE:BMY - Fitch Says Drug Approvals Are Driving Targeted Acquisitions In U.S. Pharma

The strategy in pharmaceuticals has switched from blockbuster M&A deals towards smaller targets. This trend highlights increased drug approvals by the FDA. Drug approvals have continued to grow year on year.

"We expect approvals to remain relatively strong in the intermediate term, despite lagging during the first four months of 2016," Fitch reported.

Big pharma is looking for smaller biotech and therapeutics companies to increase their drug portfolios. With big M&A deals being in a very critical environment, this seems to be the winning strategy for large firms. Even with acquisitions, companies will still focus on "innovative treatment platforms" due to "positive trends in drug development pipelines, new product commercialization and moderating patent expiry risks," Fitch noted.

Recent Big Pharma acquisitions

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.